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Is Hepatectomy Necessary in Dealing with Left
Hepatolithiasis with Intrahepatic Duct Stricture?
ABSTRACT
Sheen-Chen, S-M., Cheng, Y-F., Chou, F-F. and Lee,
T-Y. (1995). Ductal dilatation and stenting make
routine hepatectomy unnecessary for left hepato-
lithiasis with intrahepatic biliary stricture. Surgery;
117: 32-36.
Background: Hepatolithiasis with intrahepatic
biliary strictures, more common in Southeast
Asia than elsewhere, remains a difficult pro-
blem to manage. Hepatic resection has recently
been advocated as one of the treatment mod-
alities for hepatolithiasis; however, this proce-
dure is not without risk. This study was
designed to achieve complete clearance of the
stones, eliminate bile stasis, and avoid the
potential risks of hepatic resection in the
patient with hepatolithiasis and intrahepatic
biliary stricture.
Methods: In this prospective clinical trial 13
patients with retained left hepatolithiasis and
intrahepatic biliary strictures were included.
All the patients met the following criteria: (1)
initial surgical procedure for hepatolithiasis,
(2) normal gross findings of the left liver, and266 HPB INTERNATIONAL
(3) no obvious clinical evidence of an asso-
ciated intrahepatic cholangiocarcinoma. After
the operation they underwent matured T-tube
tract ductal dilatation with percutaneous trans-
hepatic cholangioscopy tube stenting. Chole-
doschoscopic electrohydraulic lithotripsy was
used in five patients after dilatation when
impacted or large stones were encountered.
Results: Complete clearance of the stones was
achieved in these 13 patients. One patient had
fevers develop after ductal dilatation, and
another patient had mild hemobilia after
electrohydraulic lithotripsy. Both recovered
uneventfully with conservative treatment.
These successfully treated patients remain
well, with a mean follow-up period of 20
months.
Conclusions: Postoperative matured T-tube
tract ductal dilatation and stenting, combined
with endoscopic electrohydraulic lithotripsy
when indicated, is an effective and safe
alternative to hepatic resection for selected left
hepatolithiasis with intrahepatic biliary stric-
ture. (SURGERY 1995; 117:32-36.)
Keywords: Intrahepatic gallstones, hepatolethia-
sis, hepatectomy, bile duct dilatation
PAPER DISCUSSION
The treatment of intrahepatic gallstones remains
controversial. In South East Asia where this
disease is frequent a clear trend has emerged in
favor of endoscopic destruction and/or removal
of intrahepatic stones associated with dilatation
and/or stenting of ductal strictures [1-5]. These
procedures have been greatly facilitated by the
development of biliary imaging and of cholan-
gioscopy and cholangioscopic electrohydraulic
or laser lithotripsy. Intrahepatic bile ducts may
be approached during operation or postop-
eratively through several routes such as dilated
T-tube tract [5] or dilated percutaneous transhe-
patic drainage tract [3], or the jejunal limb of a
hepaticocutaneous jejunostomy [1,2]. Complete
stone clearance is achieved in 75% to 90% of
patients and the rate of stone recurrence is about
15% to 20%. It is more frequent when it has not
been possible to dilate all bile duct strictures (3).
In the work published by Sheen-Chen et al. the
authors show that cholangioscopic stone retrie-
val with stricture stenting is an excellent treat-
ment in patients with hepatolithiasis localized in
the left lateral lobe. They therefore suggest that
liver resection has no more rationale in hepato-
lithiasis, even in this group of patients in whom
it was the best indication.
Such an assertion might be slightly provocative
and represent an oversimplification of the thera-
peutic approach of intrahepatic stones. Firstly the
cholangioscopic protocol is not as simple as
argued by the authors. It may require a number
of therapeutic sessions in a single patient in order
to dilate and/or stent all bile duct strictures and
to remove all stones. Despite use of semi-rigid
dilators endoscopic maneuvers in patients with
dilated bile ducts and infection are not without
risks. Two patients of their series experienced
complications. Figures were even higher in other
series [2], and the mortality rate was 3.8% in the
series of Chijiiwa et al. [4]. While the T-tube route
exposes to less risks than the transhepatic one it
can be applied only in patients who underwent
surgery as a first procedure and presented with
postoperative retained stones.
Secondly the late follow-up may not be as
good as claimed here. In another series in
Taiwan only 46% of the group of patients trea-
ted by percutaneous transhepatic cholangio-
scopy were free of symptoms with a follow-up
of 4 to 10 years [3]. There were early failures in
17% of patients and recurrent stones and/or
cholangitis after primary clearance in 38%. Rates
of recurrence between 11% and 15% despite
complete stone clearance have been reported by
others [1, 4]. Recurrence is mainly determined by
the success or failure to dilate biliary strictures
and to remove distal stones. However late
complications also occur when the liverHPB INTERNATIONAL 267
is chronically damaged by long-standing
cholestasis and cholangitis [4].
Thirdly cholangiocarcinoma occurs in about
10% of patients with hepatolithiasis[6].
Although there is no direct evidence that stones
themselves are responsible for the development
of carcinoma, mechanical irritation from the
stones, bile stasis and infection may be impor-
tant etiologic factors leading to adenomatous
epithelial hyperplasia and bile duct carcinoma.
Cholangiocarcinoma may occur a long time after
therapeutic clearance of stones as shown by
Chijiiwa et al. in a cohort of 109 treated patients
[7]. In 7 patients with onset of cholangiocarci-
noma during follow-up, 3 had no recurrent
stones. This means that a potential risk of
cholangiocarcinoma remains in these patients
whatever the success of the initial procedure.
Also when analyzing factors predisposing to
cholangiocarcinoma, Kubo et al. [6] found that
the localisation of stones predominantly in the
left lateral lobe is associated with a greater risk
of cancer than other locations. Therefore these
patients in whom Sheen-Chen and al recom-
mend conservative treatment might be those
who need more. A certain number of investiga-
tions might help in the early diagnosis of
hyperplasia and cholangiocarcinoma such as
histochemical analysis of the mucosa or dosage
of tumor markers in the bile. This may further
pinpoint patients is whom liver resection is
mandatory.
The risk of liver resection in patient with
hepatolithiasis is not high. The hospital morta-
lity averages 2% [8,9]. Left lateral lobectomy
especially are low risk surgical procedures.
Postoperative sepsis may be more frequent than
following resection for a liver tumor because of
leakage of infected bile in the operative field [8]
but its rate is decreased by intraoperative
antibiotics[10]. As observed with other treat-
ments late results after hepatectomy for hepato-
lithiasis largely depend upon the complete relief
of stones and of ductal anomalies. The best
results are obtained in patients with localized
lesions which can be totally resected, leaving a
normal remnant liver. Such patients with loca-
lized stones and ductal anomalies are not as
uncommon as usually admitted. They did
represent about two thirds of 137 patients with
hepatolithiasis in the series of Queen Mary
Hospital, Hong-Kong [1], and of 85 patients in
the series of Fukuoka, Japan [4]. In the West the
localized cases may even be more common [10].
Chijiiwa et al. have shown that results after
resection are better in patients without than in
those with previous biliary drainage [9]. This
suggests that, whenever indicated, liver resec-
tion should be performed as the first therapeutic
procedure.
Pathogenesis of hepatolithiasis is not yet
completely understood. The formation of stones
takes place because of bile stasis in dilated bile
ducts and is enhanced by infection, changes in
bile composition and/or metabolic derangement
of the liver [11]. The role of bile duct strictures is
not clear. They do not seem to be responsible for
bile duct dilatation but might rather result
secondarily from irritation by stones and cho-
langitis [12] and perpetuate bile stasis. Intrahe-
patic bile ducts dilatation might be congenital
and their distribution be segmental. With time
stones formed in the dilated ducts may migrate
into the common bile duct and/or spread
through the whole liver. Modern procedures of
liver and biliary investigations such as ultra-
sonograhy, enhanced CT scan and cholangio-
MRI, allow early recognition of hepatolithiasis in
patients with cholangitis and precise localization
of the disease. This results in avoidance of
unsuited therapeutic procedures and in the
choice of the most adapted treatment at first.
We believe that when biliary anomalies (dilata-
tion and stones) are restricted to one liver area
the best treatment offered to patients and
together the safest and least expansive is liver
resection which results in complete and defini-
tive cure [10]. When biliary anomalies are
disseminated throughout the liver relief of bile
stasis by removal of stones and dilatation of268 HPB INTERNATIONAL
strictures remains the most appropriate treat-
ment. In these cases when liver damage is
severe, liver transplantation should not be
excluded. Readers in South East Asia might
not agree which such conclusions. While hepa-
tolithiasis is much more frequent in that part of
the world than in the West it might not be so
different.
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